Ad
related to: drugs, brain development
Search results
Neuralink to test brain implant on second patient
Axios· 2 hours agoThe Food and Drug Administration has cleared Neuralink to implant its brain chip in a second patient after the company reportedly outlined fixes to an...
New menopause drugs treat hot flashes, but women may face insurance hurdles
NBC NEWS· 4 days agoNew drugs to treat debilitating menopause symptoms — namely hot flashes — are finally on the market...
Common hormone could become new dementia drug, scientists say
PA Media: Science via Yahoo News· 11 hours agoThe researchers have discovered six amino acid fragments out of the 167 within the hormone which...
Brain 'assembloids': Researchers develop first human mini-brain with fully functional blood-brain...
Medical Xpress· 9 hours agoThis major advance, published May 15 2024, in Cell Stem Cell, promises to accelerate the understanding and improve treatment of a wide range of brain disorders, including ...
US FDA Clears Neuralink's Brain Chip Implant in Second Patient: Report
Gadgets 360· 14 hours agoThe US Food and Drug Administration has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after the company offered ...
Fulgent Announces Second Drug in Development and New Prenatal Genetic Test
Los Angeles Business Journal· 11 hours agoEl Monte-based genetic testing and analysis company Fulgent Genetics Inc., which rode the Covid...
Elvis Presley's private autopsy - expert analysis of results shows how he died
Daily Express· 2 days agoWhile some suggested he had a heart attack while straining on the toilet, others pointed to his long...
IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and...
WRBL Columbus· 9 hours agoToday, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP extract of Tabernanthe iboga available for use in ibogaine ...
Ozempic maker Novo Nordisk says it will study drug’s effects on alcohol consumption but isn’t...
7 News Boston· 14 hours agoOver about three months, she told CNN in June, the medicine – which is approved for type 2 diabetes...
NKGen Biotech's SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer's Disease...
Benzinga· 14 hours agoCompany advances SNK01 into Phase 2 in moderate Alzheimer's disease; first patient...Biotech, Inc. NKGN ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the < ...